Table 2

Incidences of proliferative liver lesions after 32 weeks of PB treatment

GenotypeTreatmentnCarcinoma/adenomaCarcinomaEosinophilic adenomaOther adenoma*
Car +/+ DEN204/201/200/204/20
Car +/+ DEN+PB2020/208/2019/208/20
Car −/− DEN203/200/200/203/20
Car −/− DEN+PB190/190/190/190/19
  • * Basophilic, mixed, clear cell, or amphophilic adenoma.